Omeprazol Sandoz (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Sandoz, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Omeprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Omeprazol Sandoz, a proton pump inhibitor, is indicated for several acid‑related gastrointestinal disorders. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief by decreasing stomach acid production. - Peptic ulcer disease: promotes healing of gastric and duodenal ulcers through acid suppression. - Erosive esophagitis: facilitates mucosal recovery by maintaining a higher gastric pH. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Omeprazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild, transient pain in the head. - Abdominal pain: discomfort or cramping in the stomach area. - Diarrhea: loose, watery stools. - Nausea: feeling of sickness or urge to vomit. - Flatulence: excess gas in the gastrointestinal tract. - Constipation: infrequent or hard stools.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis associated with antibiotic‑related flora changes. - Severe allergic reactions: including anaphylaxis, rash, or swelling. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: life‑threatening skin reactions. - Hepatic enzyme elevation: significant increase in liver transaminases. - Hypomagnesemia: low blood magnesium levels with prolonged use. - Interstitial nephritis: inflammation of kidney interstitium.

Before prescribing Omeprazol Sandoz, clinicians should consider several safety aspects. - Renal function assessment: adjust use in patients with severe renal impairment. - Elderly patients: monitor for increased sensitivity to side effects. - Long‑term therapy: avoid prolonged use without medical supervision due to risk of nutrient deficiencies. - Magnesium monitoring: check serum magnesium during extended treatment. - Drug interaction review: evaluate concomitant medications that may affect omeprazole metabolism. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Omeprazole can alter the pharmacokinetics of several medicines, requiring attention to potential interactions.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir (and other protease inhibitors): markedly decreased antiviral absorption. - HIV protease inhibitors (e.g., ritonavir): significant reduction in plasma concentrations.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels, monitor cardiac function. - Phenytoin: decreased phenytoin concentrations, adjust dose if needed. - Fluconazole: elevated omeprazole levels, watch for enhanced side effects. - Calcium carbonate and iron salts: reduced absorption of these minerals, separate dosing times.